Colon cancer used to feel like a worry for later-something to think about decades down the road. Not anymore. An estimated ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare ...

They told me it was effective, and I knew mailing a Cologuard box back would be pretty dang easy.” Cologuard — a simple way ...

This medical services stock is in a buy zone of a cup base. The firm's losses are dwindling.

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

A new test could be an option for the 40% of Americans over age 45 who are not up to date with screenings. The Food and Drug Administration provided final approval on Monday for a new colorectal ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Colon cancer is a leading cause of cancer-related deaths.

A major European trial has pushed colonoscopy back into the medical spotlight. After 13 years, the NordICC study found that ...

The American Cancer Society recently recommended that two blood tests can be an option for people who won't get a colonoscopy or do a stool test. No one looks forward to a colonoscopy, but for the ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...